An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.

File SB946 ("An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and providing for tianeptine-related adverse health events.") is before the Pennsylvania Legislature and has not been decided. Latest step (July 23, 2025): Referred to HEALTH AND HUMAN SERVICES, July 23, 2025.

Pennsylvania file SB946, before the Pennsylvania Legislature. No action in 485 days as of 2025-07-23.

Official summary

Sponsor's co-sponsorship memo title: Bill to Classify Tianeptine as a Schedule II Controlled Substance.

Read the official record for SB946

See everything up for a vote · This week in Pennsylvania · See what we have filed with the clerk